2 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Withdrawn 1 |
Follow Fletikumab: new trials by email Literature Review of Fletikumab trials Research Report on Fletikumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate NNC0109-0012, Adalimumab, placebo - Inflammation, Rheumatoid Arthritis | Phase 2 | Withdrawn | Novo Nordisk A/S | 2014-09-01 | 2014-08-15 | |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate NNC0109-0012, placebo - Inflammation, Rheumatoid Arthritis | Phase 2 | Terminated | Novo Nordisk A/S | 298 | 2012-10-30 | 2018-09-05 |
| A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics NNC0109-0012, placebo - Inflammation, Rheumatoid Arthritis | Phase 2 | Terminated | Novo Nordisk A/S | 239 | 2012-08-01 | 2018-09-05 |
Arthritis, Rheumatoid (3) · Inflammation (3)
Novo Nordisk A/S (3)
Argentina (2) · Belgium (2) · Brazil (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Italy (2) · Mexico (2) · Poland (2) · Spain (2) · United States (2) · Russia (1) · Ukraine (1) · United Kingdom (1)